231 related articles for article (PubMed ID: 12076394)
1. Interferon for interferon naive patients with chronic hepatitis C.
Myers RP; Regimbeau C; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski JP; Poynard T
Cochrane Database Syst Rev; 2002; 2002(2):CD000370. PubMed ID: 12076394
[TBL] [Abstract][Full Text] [Related]
2. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Myers RP; Poynard T
Cochrane Database Syst Rev; 2002; (4):CD003617. PubMed ID: 12519606
[TBL] [Abstract][Full Text] [Related]
3. Interferon for acute hepatitis C.
Poynard T; Regimbeau C; Myers RP; Thevenot T; Leroy V; Mathurin P; Opolon P; Zarski JP
Cochrane Database Syst Rev; 2002; 2001(1):CD000369. PubMed ID: 11869573
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin with or without alpha interferon for chronic hepatitis C.
Kjaergard LL; Krogsgaard K; Gluud C
Cochrane Database Syst Rev; 2002; (2):CD002234. PubMed ID: 12076442
[TBL] [Abstract][Full Text] [Related]
5. Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.
Kjaergard LL; Krogsgaard K; Gluud C
Cochrane Database Syst Rev; 2002; (1):CD002234. PubMed ID: 11869633
[TBL] [Abstract][Full Text] [Related]
6. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
Koretz RL; Pleguezuelo M; Arvaniti V; Barrera Baena P; Ciria R; Gurusamy KS; Davidson BR; Burroughs AK
Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003617. PubMed ID: 23440791
[TBL] [Abstract][Full Text] [Related]
7. WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.
Gluud LL; Krogsgaard K; Gluud C
Cochrane Database Syst Rev; 2007 Jul; 2002(2):CD002234. PubMed ID: 17636700
[TBL] [Abstract][Full Text] [Related]
8. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 update.
Thévenot T; Regimbeau C; Ratziu V; Leroy V; Opolon P; Poynard T
J Viral Hepat; 2001 Jan; 8(1):48-62. PubMed ID: 11155152
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin plus interferon versus interferon for chronic hepatitis C.
Brok J; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2005 Jul; (3):CD005445. PubMed ID: 16034976
[TBL] [Abstract][Full Text] [Related]
10. Ribavirin plus interferon versus interferon for chronic hepatitis C.
Brok J; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2010 Jan; (1):CD005445. PubMed ID: 20091577
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration.
Poynard T; Leroy V; Cohard M; Thevenot T; Mathurin P; Opolon P; Zarski JP
Hepatology; 1996 Oct; 24(4):778-89. PubMed ID: 8855176
[TBL] [Abstract][Full Text] [Related]
12. Telaprevir for genotype 1 chronic hepatitis C: a systematic review and meta-analysis.
Gu L; Chen Q; Xie J; Yan Y; Wu G; Tan J; Liang B; Chen W; Wu P; Su L; Tang N
Pharmazie; 2012 Dec; 67(12):963-72. PubMed ID: 23346756
[TBL] [Abstract][Full Text] [Related]
13. Effects of adding ribavirin to interferon to treat chronic hepatitis C infection: a systematic review and meta-analysis of randomized trials.
Brok J; Gluud LL; Gluud C
Arch Intern Med; 2005 Oct; 165(19):2206-12. PubMed ID: 16246984
[TBL] [Abstract][Full Text] [Related]
14. Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus.
Iorio A; Marchesini E; Awad T; Gluud LL
Cochrane Database Syst Rev; 2010 Jan; (1):CD004888. PubMed ID: 20091566
[TBL] [Abstract][Full Text] [Related]
15. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.
Katz LH; Goldvaser H; Gafter-Gvili A; Tur-Kaspa R
Cochrane Database Syst Rev; 2012 Sep; (9):CD008516. PubMed ID: 22972122
[TBL] [Abstract][Full Text] [Related]
16. Ribavirin monotherapy for chronic hepatitis C.
Brok J; Gluud L; Gluud C
Cochrane Database Syst Rev; 2005 Oct; (4):CD005527. PubMed ID: 16235408
[TBL] [Abstract][Full Text] [Related]
17. Bile acids for viral hepatitis.
Chen W; Liu J; Gluud C
Cochrane Database Syst Rev; 2003; (2):CD003181. PubMed ID: 12804455
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients.
Fabrizi F; Dulai G; Dixit V; Bunnapradist S; Martin P
Aliment Pharmacol Ther; 2003 Dec; 18(11-12):1071-81. PubMed ID: 14653826
[TBL] [Abstract][Full Text] [Related]
19. Interferon and ribavirin for patients with chronic hepatitis C who did not respond to previous interferon therapy: a meta-analysis of controlled and uncontrolled trials.
Cheng SJ; Bonis PA; Lau J; Pham NQ; Wong JB
Hepatology; 2001 Jan; 33(1):231-40. PubMed ID: 11124841
[TBL] [Abstract][Full Text] [Related]
20. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.
Gordon CE; Uhlig K; Lau J; Schmid CH; Levey AS; Wong JB
Am J Kidney Dis; 2008 Feb; 51(2):263-77. PubMed ID: 18215704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
